Where does Kodiak Sciences Inc's cash flow data come from?

Every line is extracted from Kodiak Sciences Inc's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Kodiak Sciences Inc KOD Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$230.66M-0.3%	-$229.97M-5.8%	-$217.34M-8.8%	-$199.83M-4.8%	-$190.63M-8.2%
Depreciation and amortization	$17.83M-2.7%	$18.33M-0.4%	$18.41M-0.5%	$18.51M-0.5%	$18.61M-0.5%
Stock-based compensation	$55.13M-6.3%	$58.86M+8.6%	$54.2M-1.4%	$54.96M-4.7%	$57.7M-4.2%
Gain (loss) on sale of assets	——	——	——	——	-$8K—
Change in accounts payable	——	——	——	——	——
Change in accrued liabilities	$11.48M+23.8%	$9.28M—	——	——	——
Change in other assets	$1.89M+113%	$891K—	——	——	——
Other working capital changes	——	$20K+33.3%	$15K+50.0%	$10K+100%	$5K—
Non-cash operating lease expense	$8.1M+1.3%	$7.99M-1.1%	$8.08M-0.7%	$8.14M-0.5%	$8.18M+2.3%
Change in operating lease liabilities	-$11.65M-4.3%	-$11.17M+0.6%	-$11.23M-6.5%	-$10.55M+1.3%	-$10.68M+5.1%
Net cash from operating activities	-$146.94M-8.0%	-$136.01M-7.3%	-$126.7M-10.2%	-$114.98M-7.7%	-$106.8M+9.0%
Capital expenditures	$1.18M+133%	$506K-13.8%	$587K-17.0%	$707K+13.5%	$623K+66.1%
Net cash from investing activities	-$1.18M-133%	-$506K+13.8%	-$587K+19.8%	-$732K+14.8%	-$859K-13.8%
Proceeds from issuance of common stock	$5.96M+15.5%	$5.16M+288%	$1.33M—	——	——
Net cash from financing activities	$178.8M+0.3%	$178.3M+12,104%	$1.46M+125%	$648K+10.4%	$587K+17.2%
Net increase (decrease) in cash	$30.68M-26.6%	$41.79M+133%	-$125.83M-9.4%	-$115.06M-7.5%	-$107.07M+8.9%
Depreciation	$17.83M-2.7%	$18.33M-0.4%	$18.41M-0.5%	$18.51M-0.5%	$18.61M-0.5%
Gain (Loss) on Derivative Instruments, Net, Pretax	——	$0—	——	——	——
Gain (Loss) on Disposition of Assets	——	——	——	——	——
Impairment Of Leasehold	——	——	——	——	$1.91M—
Accrued expenses and other liabilities	$11.48M+23.8%	$9.28M—	——	——	——
Operating lease liabilities	-$11.65M-4.3%	-$11.17M+0.6%	-$11.23M-6.5%	-$10.55M+1.3%	-$10.68M+5.1%
Increase (Decrease) in Other Operating Assets	——	——	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$1.89M+113%	$891K—	——	——	——
Operating lease right-of-use asset amortization	$8.1M+1.3%	$7.99M-1.1%	$8.08M-0.7%	$8.14M-0.5%	$8.18M+2.3%
Payment Of Public Offering Costs	——	——	——	——	——
Net proceeds from sales of subsidiary shares	——	$172.96M+33.3%	$129.72M+50.0%	$86.48M+100%	$43.24M—
Cash In Transit For Stock Option Exercises	——	$201K+33.3%	$150.75K+50.0%	$100.5K+100%	$50.25K—
Increase Decrease In Operating Lease Liability	-$11.65M-4.3%	-$11.17M+0.6%	-$11.23M-6.5%	-$10.55M+1.3%	-$10.68M+5.1%
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1	——	——	——	——	——
Reclassification Of Deposits To Property And Equipment	——	$0+100%	-$6.25K+50.0%	-$12.5K+33.3%	-$18.75K+25.0%
Free cash flow	-$148.12M-8.5%	-$136.51M-7.2%	-$127.29M-10.0%	-$115.68M-7.7%	-$107.42M+8.7%
Free cash flow	-$148.12M-8.5%	-$136.51M-7.2%	-$127.29M-10.0%	-$115.68M-7.7%	-$107.42M+8.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Kodiak Sciences Inc's cash flow data come from?: Every line is extracted from Kodiak Sciences Inc's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.